US2010109510A1PendingUtilityA1
Functionalized carbon nanotubes
Assignee: APPLIED NANOTECH HOLDINGS INCPriority: Jan 23, 2006Filed: Sep 22, 2009Published: May 6, 2010
Est. expiryJan 23, 2026(expired)· nominal 20-yr term from priority
Inventors:Zvi Yaniv
G01N 33/544Y10S977/707Y10S977/746B82Y 5/00C12Q 1/6825Y10S977/702C12Q 1/6834
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Carbon nanotubes are grown on a first substrate. The CNTs grown on the first substrate are immersed in a biological solution at a predetermined depth to functionalize ends of the CNTs with a biological molecule. The functionalized CNTs are harvested from the first substrate. A second substrate is functionalized with a complementary biological modification, which is a complementary binding partner to the biological molecule functionalized to the ends of the CNTs. The functionalized CNTs are attached to the second substrate by way of the complementary binding partner.
Claims
exact text as granted — not AI-modified1 . A method comprising:
growing carbon nanotubes (CNTs) on a first substrate; immersing the CNTs grown on the first substrate in a biological solution at predetermined depth to functionalize ends of the CNTs with a biological molecule; harvesting the functionalized CNTs from the first substrate; functionalizing a second substrate with a complementary biological modification, which is a complementary binding partner to the biological molecule functionalized to the ends of the CNTs; and; to attaching the functionalized CNTs to the second substrate by way of the complementary binding partner.
2 . The method as recited in claim 1 , wherein the biological solution comprises a protein.
3 . The method as recited in claim 1 , wherein the biological solution comprises DNA.
4 . The method as recited in claim 1 , wherein the biological solution comprises a carbohydrate.
5 . The method as recited in claim 2 , wherein the complementary biological modification comprises a protein.
6 . The method as recited in claim 3 , wherein the complementary biological modification comprises DNA.
7 . The method as recited in claim 4 , wherein the complementary biological modification comprises a carbohydrate.
8 . The method as recited in claim 1 , wherein the CNTs gown on the first substrate have varying lengths, and only CNTs having lengths of at least a predetermined length are functionalized with the biological molecule.
9 . The method as recited in claim 1 , further comprising:
Positioning an anode a predetermined distance from the second substrate with the attached functionalized CNTs.
10 . A field emission device comprising a cathode comprising a substrate with functionalized CNTs attached thereto by way of biological complementary binding pairs.
11 . The field emission device as recited in claim 10 , further comprising an anode positioned a predetermined distance from the cathode.
12 . The field emission device as recited in claim 11 , wherein the anode further comprises a phosphor deposited on a substrate that emits light in response to bombardment of electrons emitted from the cathode under an influence of an electric field.
13 . The field emission device as recited in claim 10 , wherein the biological complementary binding pairs comprise DNA.
14 . The field emission device as recited in claim 10 , wherein the biological complementary binding pairs comprise biotin and streptavidin.
15 . The method as recited in claim 1 , wherein the biological solution comprises streptavidin, and the complementary binding partner comprises biotin.
16 . The method as recited in claim 1 , wherein the biological solution comprises biotin, and the complementary binding partner comprises streptavidin.Join the waitlist — get patent alerts
Track US2010109510A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.